Updates are available Correction dated 2023-05-10
Click to view Correction: https://doi.org/10.1038/s41588-023-01412-z
-
Authors
Solé-Navais, Pol http://orcid.org/0000-0002-3326-266X
Flatley, Christopher
Steinthorsdottir, Valgerdur http://orcid.org/0000-0003-1846-6274
Vaudel, Marc http://orcid.org/0000-0003-1179-9578
Juodakis, Julius http://orcid.org/0000-0001-5600-974X
Chen, Jing http://orcid.org/0000-0002-6227-7393
Laisk, Triin http://orcid.org/0000-0003-1501-9030
LaBella, Abigail L. http://orcid.org/0000-0003-0068-6703
Westergaard, David http://orcid.org/0000-0003-0128-8432
Bacelis, Jonas http://orcid.org/0000-0002-2450-732X
Brumpton, Ben http://orcid.org/0000-0002-3058-1059
Skotte, Line http://orcid.org/0000-0002-7398-1271
Borges, Maria C.
Helgeland, Øyvind http://orcid.org/0000-0002-5612-2985
Mahajan, Anubha http://orcid.org/0000-0001-5585-3420
Wielscher, Matthias http://orcid.org/0000-0003-4138-1383
Lin, Frederick http://orcid.org/0000-0003-1670-6086
Briggs, Catherine
Wang, Carol A. http://orcid.org/0000-0002-4301-3974
Moen, Gunn-Helen http://orcid.org/0000-0002-8768-0904
Beaumont, Robin N. http://orcid.org/0000-0003-0750-8248
Bradfield, Jonathan P.
Abraham, Abin
Thorleifsson, Gudmar http://orcid.org/0000-0003-4623-9087
Gabrielsen, Maiken E.
Ostrowski, Sisse R. http://orcid.org/0000-0001-5288-3851
Modzelewska, Dominika
Nohr, Ellen A.
Hypponen, Elina http://orcid.org/0000-0003-3670-9399
Srivastava, Amit
Talbot, Octavious
Allard, Catherine http://orcid.org/0000-0002-8829-4984
Williams, Scott M. http://orcid.org/0000-0002-4835-9544
Menon, Ramkumar
Shields, Beverley M.
Sveinbjornsson, Gardar http://orcid.org/0000-0003-2429-9468
Xu, Huan
Melbye, Mads
Lowe, William Jr http://orcid.org/0000-0001-9467-3422
Bouchard, Luigi
Oken, Emily
Pedersen, Ole B. http://orcid.org/0000-0003-2312-5976
Gudbjartsson, Daniel F. http://orcid.org/0000-0002-5222-9857
Erikstrup, Christian http://orcid.org/0000-0001-6551-6647
Sørensen, Erik
,
McCarthy, Mark I.
,
,
Lie, Rolv T.
Teramo, Kari
Hallman, Mikko
Juliusdottir, Thorhildur
Hakonarson, Hakon
Ullum, Henrik
Hattersley, Andrew T. http://orcid.org/0000-0001-5620-473X
Sletner, Line
Merialdi, Mario
Rifas-Shiman, Sheryl L.
Steingrimsdottir, Thora
Scholtens, Denise http://orcid.org/0000-0002-8252-7863
Power, Christine
West, Jane http://orcid.org/0000-0002-5770-8363
Nyegaard, Mette http://orcid.org/0000-0003-4973-8543
Capra, John A.
Skogholt, Anne H. http://orcid.org/0000-0001-7466-0405
Magnus, Per
Andreassen, Ole A. http://orcid.org/0000-0002-4461-3568
Thorsteinsdottir, Unnur
Grant, Struan F. A. http://orcid.org/0000-0003-2025-5302
Qvigstad, Elisabeth
Pennell, Craig E. http://orcid.org/0000-0002-0937-6165
Hivert, Marie-France http://orcid.org/0000-0001-7752-2585
Hayes, Geoffrey M. http://orcid.org/0000-0002-4617-3981
Jarvelin, Marjo-Riitta http://orcid.org/0000-0002-2149-0630
McCarthy, Mark I.
Lawlor, Deborah A. http://orcid.org/0000-0002-6793-2262
Nielsen, Henriette S. http://orcid.org/0000-0003-2106-8103
Mägi, Reedik http://orcid.org/0000-0002-2964-6011
Rokas, Antonis http://orcid.org/0000-0002-7248-6551
Hveem, Kristian
Stefansson, Kari http://orcid.org/0000-0003-1676-864X
Feenstra, Bjarke http://orcid.org/0000-0003-1478-649X
Njolstad, Pål http://orcid.org/0000-0003-0304-6728
Muglia, Louis J.
Freathy, Rachel M. http://orcid.org/0000-0003-4152-2238
Johansson, Stefan http://orcid.org/0000-0002-2298-7008
Zhang, Ge
Jacobsson, Bo http://orcid.org/0000-0001-5079-2374
- License Information
-
More Information
Article History
Received: 4 May 2022
Accepted: 22 February 2023
First Online: 3 April 2023
Change Date: 10 May 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41588-023-01412-z
Competing interests
: As of January 2020, A.M. is an employee of Genentech and a holder of Roche stock. The views expressed in this article are those of the author(s) and not necessarily those of the NHS, NIHR or Department of Health. M.I.M. has served on advisory panels for Pfizer, Novo Nordisk and Zoe Global; has received honoraria from Merck, Pfizer, Novo Nordisk and Eli Lilly; and has received research funding from Abbvie, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Janssen, Merck, Novo Nordisk, Pfizer, Roche, Sanofi Aventis, Servier and Takeda. As of June 2019, M.I.M. is an employee of Genentech and a holder of Roche stock. D.A.L. receives support from several national and international government and charitable research funders, as well as from Medtronic and Roche Diagnostics for research unrelated to that presented here. H.S. obtained speaker fees from Ferring Pharmaceuticals, Merck A/S, AstraZeneca and Cook Medical. V.S., G.T., G.S., D.F.G., U.T. and K.S. are employees of deCODE genetics/Amgen. The remaining authors declare no competing interests.
